REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $657,000 | -13.9% | 23,171 | -23.6% | 0.10% | -20.2% |
| Q3 2020 | $763,000 | -12.6% | 30,345 | -54.8% | 0.12% | -5.6% |
| Q3 2019 | $873,000 | -35.6% | 67,141 | -35.7% | 0.13% | -34.7% |
| Q2 2019 | $1,355,000 | +229.7% | 104,463 | +412.1% | 0.19% | +211.3% |
| Q4 2018 | $411,000 | -58.6% | 20,399 | -49.0% | 0.06% | -53.7% |
| Q3 2018 | $993,000 | +44.8% | 39,960 | +60.0% | 0.13% | +38.1% |
| Q2 2018 | $686,000 | – | 24,974 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |